There are few cancers that are as tough to beat as pancreatic cancer. When it is found, the disease has usually spread, and only about 20 percent of newly-diagnosed patients are eligible for surgery. But if there is ever a time when there are high hopes for new ways to detect and treat it, the time is now. Scientists at Johns(...)
Research
The Top Ten of 10
Posted by Valerie Matthews-Mehl | precision medicine, ResearchThe Top Ten of 10 As we look ahead to a 2011 filled with new cancer discoveries, let’s take a moment to revisit the Johns Hopkins Kimmel Cancer Center’s top advances of 2010: #1: Personalized Cancer Medicine Becomes a Reality World renowned investigator Bert Vogelstein, M.D., and team pioneered the science that has led to(...)
Dec 28, 2010
Cancer News Review: Top Stories
Posted by Vanessa Wasta | ResearchThree stories top the list of major developments in cancer research during the past month. Listen to these topics discussed in the most recent Cancer News Review podcast. First, to treat or not to treat is the question for low-risk prostate cancer. Whether to give aggressive treatments for low-risk cancer contained within the prostate is(...)
Dec 22, 2010 No comments
Top Cancer Research News: November
Posted by Vanessa Wasta | ResearchIn Kimmel Cancer Center director Bill Nelson's podcast, top stories included studies on pancreatic, colon and kidney cancer.
Dec 2, 2010 No comments
Let’s Beat Pancreatic Cancer Together
Posted by Vanessa Wasta | ResearchThe following blog post was submitted and written by representatives at the Lustgarten Foundation. Johns Hopkins and the Sanger Institute published two papers in the journal Nature describing how pancreatic cancer develops far more slowly than once thought. Major media outlets covering the news included The New York Times, Bloomberg News, Reuters, CBS News, Science News,(...)
Oct 29, 2010 No comments
Top Cancer Research News: October
Posted by Vanessa Wasta | ResearchIn this month's Cancer News Review podcast, Cancer Center director Bill Nelson reviews top headlines in cancer research. Each of the studies discussed here were published in the Oct. 2 issue of the Lancet.
Oct 27, 2010 3 comments
What Matters to You?
Posted by Vanessa Wasta | Issues & Perspectives, ResearchIt was the culmination of years of effort by many scientists and physicians and the bravery of patients to try something new that has brought some steady hope in an experimental therapy called epigenetics.
Oct 1, 2010 No comments